Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec;11(12):5649-5651.
doi: 10.21037/jtd.2019.11.19.

Local consolidative therapy for oligometastatic non-small cell lung cancer

Pamela P Samson  1   2 , Matthew B Spraker  1   2 , Shahed N Badiyan  1   2 , Gregory Vlacich  1   2 , Clifford G Robinson  1   2 , Aadel A Chaudhuri  1   2
Affiliations
Editorial

Local consolidative therapy for oligometastatic non-small cell lung cancer

Pamela P Samson et al. J Thorac Dis. 2019 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: CGR has research support from Varian Medical Systems, Elekta and Merck, consulting agreements with Varian Medical Systems, EMD Serono, AstraZeneca and Radialogica, and stocks with Radialogica. AAC reports speaker honoraria and travel support from Varian Medical Systems, Roche and Foundation Medicine, research support from Roche, and has served as an advisor/consultant for Tempus Labs, Roche, Geneoscopy, Fenix Group International and Oscar Health. The other authors have no conflicts of interest to declare.

Comment on

References

    1. Khan AJ, Mehta PS, Zusag TW, et al. Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC). Radiother Oncol 2006;81:163-7. 10.1016/j.radonc.2006.09.006 - DOI - PubMed
    1. Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol 2011;8:378-82. 10.1038/nrclinonc.2011.44 - DOI - PubMed
    1. Macdermed DM, Weichselbaum RR, Salama JK. A rationale for the targeted treatment of oligometastases with radiotherapy. J Surg Oncol 2008;98:202-6. 10.1002/jso.21102 - DOI - PubMed
    1. Gomez DR, Tang C, Zhang J, et al. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. J Clin Oncol 2019;37:1558-65. 10.1200/JCO.19.00201 - DOI - PMC - PubMed
    1. Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 2019;393:2051-8. 10.1016/S0140-6736(18)32487-5 - DOI - PubMed